BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Czubkowski P, Osiecki M, Szymańska E, Kierkuś J. The risk of cardiovascular complications in inflammatory bowel disease. Clin Exp Med 2020;20:481-91. [PMID: 32785793 DOI: 10.1007/s10238-020-00639-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mironova OI, Isaikina MA, Khasieva SA. Аtherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Terapevticheskii arkhiv 2022;93:1533-8. [DOI: 10.26442/00403660.2021.12.201225] [Reference Citation Analysis]
2 Xu G, Xing G, Zhang B, Zhu J, Cai Y, Shen T, Rao J, Shi R, Cao Z, Nguyen T. The Relieving Effects of a Polyherb-Based Dietary Supplement ColonVita on Gastrointestinal Quality of Life Index (GIQLI) in Older Adults with Chronic Gastrointestinal Symptoms Are Influenced by Age and Cardiovascular Disease: A 12-Week Randomized Placebo-Controlled Trial. Evid Based Complement Alternat Med 2021;2021:6653550. [PMID: 34539805 DOI: 10.1155/2021/6653550] [Reference Citation Analysis]
3 Bu Y, Wu H, Deng R, Wang Y. Therapeutic Potential of SphK1 Inhibitors Based on Abnormal Expression of SphK1 in Inflammatory Immune Related-Diseases. Front Pharmacol 2021;12:733387. [PMID: 34737701 DOI: 10.3389/fphar.2021.733387] [Reference Citation Analysis]